Brain research supported by the European Union
|
|
|
- Charlene Abigayle Lindsey
- 6 years ago
- Views:
Transcription
1 Brain research supported by the European Union Lara Passante, PhD Health Directorate Directorate-General for Research & European Commission FENS Featured Regional Meeting Septembre 2013 Prague
2 Neuroscience: Seventh Framework Programme Horizon 2020
3 Current EC health research activities Total FP7 budget: 54.6 billion Health Priority in Cooperation: 6.1 billion JRC (EC) Euratom 1.8 Capacities People Ideas Cooperation 32.3
4 FP7 Health state of play 4 billion EUR currently invested in 844 on-going collaborative projects ~3000 organisations from 122 countries involved Leading role in 6 global research consortia 1 billion EUR investment in Europe's largest public-private initiative for better and safer medicines
5 What type of disease? Euratom JRC Capacities People Cooperation 400 Ideas ,5 Billion Euro
6 FP7 Brain Research Overall FP7 funding support for brain research Brain functions and processes Neurodegenerative disorders Neurological disorders (excl. neurodegenerative Neuropsychiatric disorders Public Health Rare brain disorders EUR 1.98 billion
7 Overall FP7 funding support for research on neurological disorders (excl. neurodegenerative) FP7 Brain Research Neurosurgical diseases Other Neurological diseases Neuroinflammatory diseases Neurological infectious diseases EUR 460 million
8 FP7 Brain Research Overall FP7 funding support for research on neurodegenerative diseases Alzheimer's disease Parkinson's disease Other neurodegenerative diseases Motorneuron diseases Retinal diseases Lysosomal storage diseases EUR 563 million
9 FP7 Brain Research Overall FP7 funding support for research on neuropsychiatric diseases Schizophrenia Other psychiatric diseases Autism Depression + Bipolar disorders EUR 300 million
10 Contribution to EU27 and Associated countries FP7 Brain Research
11 FP7 Brain Research FP7 Brain research : EU27 and Associated countries connections
12 Month of the Brain Month of the Brain: Draft Stakeholders Recommended policy principles and objectives-draft (1/3): 1. Promote the role of patients in all stages of research and evidence-based healthcare 2. Tackle the stigmatization of patients with brain disorders 3. Continue supporting interdisciplinary research approaches
13 Month of the Brain Draft Stakeholders Recommended policy principles and objectives (2/3): 4. Foster innovative and more relevant approaches to clinical development 5. Promote new ways of implementing healthcare solutions 6. Encourage data sharing 7. Attract and align public and private investment into brain research and healthcare 8. Expand smart and innovative strategies for supporting brain research and healthcare
14 Month of the Brain Draft Stakeholders Recommended policy principles and objectives (3/3): 9. Reward innovation in drug development, new technologies and healthcare delivery 10.Adapt the regulatory landscape Month of the Brain at: brain-month/index_en.cfm
15 Horizon 2020 Horizon 2020: The next framework programme for research and innovation Europe needs cutting edge research and innovation Essential to ensure competitiveness, growth and jobs Vital to tackle pressing societal challenges 3% of GDP invested in R&D: headline target of Europe 2020
16 Horizon 2020 Three priorities: 1. Excellent science 2. Industrial leadership 3. Societal challenges
17 Horizon 2020 What s new A single programme bringing together three separate programmes/initiatives Coupling research to innovation from research to retail, all forms of innovation Focus on societal challenges facing EU society, e.g. health, clean energy and transport Simplified access, for all companies, universities, institutes in all EU countries and beyond.
18 Horizon 2020 Towards Horizon 2020: more money for health research in times of austerity? Investing into the right research pays off: Better, more personalised and costefficient treatments Fewer chronic patients will drive down healthcare costs Greater focus on innovation Growth and jobs
19 Horizon 2020 The Health Challenge: some of the key features Understanding health, wellbeing and disease Preventing disease Treating and managing Active ageing and selfmanagement of health Adapting to an ageing population Personalised medicine Translational research Clinical trials Private sector competitiveness, capability Coordination of national efforts Methods and data Health care provision and integrated care Reduce costs: CER Expanding global cooperation
20 Follow Horizon 2020 at: n.cfm Month of the Brain at: ain-month/index_en.cfm Thank you for your attention
Gesundheit in Horizont 2020
Wien, 5, Dezember 2013 Gesundheit in Horizont 2020 Gesellschaftliche Herausforderung 1: Gesundheit, demografischer Wandel und Wohlergehen Dr Elmar Nimmesgern GD Forschung und Innovation Europäische Kommission
Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation
European efforts in Mental Health research Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation European Commission Conference on Psychotherapy in Europe EP, Brussels 9 February 2012
EU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission
EU support to hepatitis research Anna Lönnroth Sjödén Health Research DG Research - European Commission Hepatitis B and C Summit, Brussels, 15 October 2010 1 Main Objectives: to improve quality of life
Horizon Introduction. Alex Harris Medical Research Council
Horizon 2020 - Introduction Alex Harris Medical Research Council Agenda MRC and Horizon 2020 UK Success Rate (FP7 Health) What is Horizon 2020? The Horizon 2020 Health Challenge NCP support MRC and Horizon
Future of diabetes research in the EU- the EC perspectives
Future of diabetes research in the EU- the EC perspectives Dr Karim Berkouk, Deputy Head of Unit DG for Health Directorate European Commission Overview Challenges in diabetes Research in diabetes at EU
New Horizons for Vaccine R&D&I in Europe
New Horizons for Vaccine R&D&I in Europe Health, Demographic Change and Wellbeing Ruxandra Draghia-Akli MD, PhD Directorate E - Health Research DG - Research & Innovation European Commission Why EU support
Cancer Research in the EU Framework Programmes for RTD
Cancer Research in the EU Framework Programmes for RTD Action against cancer: European platform Maria Vidal, MD, PhD Deputy Head of Unit Medical and public health research Health Directorate DG Research
Counting down to zero
12%... 10%... 8%... Counting down to zero Towards a future with underfunded health research? We, as representatives of the undersigned organisations, welcome the current European Commission s proposal
Pain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki
Pain and Palliative care in the European Commission s Framework Programmes European Commission Research DG Dr. Elengo Manoussaki European Parliament resolution on combating cancer in the enlarged EU Calls
1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.
Council of the European Union Brussels, 26 November 2015 (OR. en) 14395/15 SAN 391 NOTE From: To: Subject: General Secretariat of the Council Permanent Representatives Committee/Council Employment, Social
Council of the European Union Brussels, 28 October 2015 (OR. en)
Conseil UE Council of the European Union Brussels, 28 October 2015 (OR. en) PUBLIC 13261/15 LIMITE SAN 347 NOTE From: To: Subject: General Secretariat of the Council Working Party on Public Health Draft
DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH
DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH Brussels, 19 March 2015 Michael Hübel Programme Management and Diseases Directorate-General for Health and Food Safety European Commission
The Innovative Medicines Initiative: an engine for therapeutic innovation
The Innovative Medicines Initiative: an engine for therapeutic innovation Michel Goldman 26.11.2014 Brussels Bringing health-related life science and technology sectors into IMI2 The pillars of innovation
Moving towards 2020 priorities for Public Health for the years Health and Consumers
Moving towards 2020 priorities for Public Health for the years 2013-20 Health in the MFF 2014-2020 Commission proposal for the Health for Growth Programme 2014-2020 http://ec.europa.eu/health/programme/policy/index_en.htm
Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.
Alcohol and Drug Commissioning Framework for Northern Ireland 2013-16 Consultation Questionnaire. This questionnaire has been designed to help stakeholders respond to the above framework. Written responses
Welcome Note by Dr. Helge Braun, Parliamentary State Secretary
Welcome Note by Dr. Helge Braun, Parliamentary State Secretary German Federal Ministry of Education and Research on the occasion of ERA-Net NEURON Final Conference October-27, 2011 Berlin, Germany Es gilt
Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board
Joint Programming Initiative on Neurodegenerative Diseases Prof. Philippe Amouyel Chair, JPND Management Board Cases / 100 Alzheimer s disease in Europe 40 Number of cases Societal costs ( ) 2010 6,000,000
BRAIN MISSION Understand - fix - enhance
THE EUROPEAN BRAIN COUNCIL PRESENTS BRAIN MISSION Understand - fix - enhance THE space race OF the 21st century A major societal challenge The brain is the most complex human organ. It provides and controls
CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU
CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU July December 2012 Research Symposium on Digestive and Liver Diseases Brussels, 18 September 2012 Dr Myrto Azina- Chronides Ministry of Health Cyprus Digestive
What EU research policy can do for conditions such as chronic pain?
The EU Framework Programme for Research and Innovation HORIZON 2020 What EU research policy can do for conditions such as chronic pain? K Berkouk, PhD Deputy Head of Unit, Non-communicable diseases and
14414/15 AF/evt 1 DG G 3 C
Council of the European Union Brussels, 25 November 2015 (OR. en) 14414/15 RECH 282 COMPET 531 SOC 684 NOTE From: Permanent Representatives Committee (Part 1) To: Council No. prev. doc.: 13902/15 RECH
Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee
Horizon 2020 - societal challenge 1 Health, demographic change and wellbeing Work Programme 2014-2015 Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee HORIZON 2020 Work Programmes
A progress report on the Joint Programming Initiative
A progress report on the Joint Programming Initiative In April 2010, Alzheimer Europe talked about the aims of the Joint Programming Initiative on Neurodegenerative Diseases (JPND) with the Initiative
Future of Diabetes Research in Europe JDRF Perspective
Future of Diabetes Research in Europe JDRF Perspective IMI-JDRF Diabetes Patient Meeting 20 May 2014 Brussels, Belgium Olivier ARNAUD, Pharm D JDRF European Research Director oarnaud@jdrf.org Future of
Health and well-being a perspective from WHO
Meeting of Chief Medical Officers and Chief Nursing Officers Health and well-being a perspective from WHO Zsuzsanna Jakab WHO Regional Director for Europe Health 2020 European policy framework Health 2020
Joint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
Filling Research Gaps to meet the Malnutrition Challenge : building evidences
1 Filling Research Gaps to meet the Malnutrition Challenge : building evidences 20th meeting of the EC-US Task Force on Biotechnology Research 3-4 June 2010, Barcelona Isabelle de Froidmont-Göertz Unit
The European Framework Program for Research & Innovation: Horizon 2020: Health, demographic change & wellbeing
The European Framework Program for Research & Innovation: Horizon 2020: Health, demographic change & wellbeing Sasha Hugentobler National Contact Point Health Euresearch Head Office phone +41 31 380 60
An overview of EU funding for Brain and Related Diseases. Aldo Tagliabue
An overview of EU funding for Brain and Related Diseases Aldo Tagliabue FP7 2007-2013 50.5 Billion for the Specific Programmes JRC Euratom 1.947 Cooperation 1.751 32.365 Capacities 4.217 People 4.728 Ideas
Clusters in Sports Industry: EU Approach and Support
Enterprise and Industry José Freitas Policy Officer SMEs: Clusters and Emerging Industries unit Clusters in Sports Industry: EU Approach and Support EPSI Conference on Sports and Innovation June 13 th,
Horizon Tailored screening as a research challenge. Mireille Broeders 30 January 2014, Bologna
Horizon 2020 Tailored screening as a research challenge Mireille Broeders 30 January 2014, Bologna Dept for Health Evidence, Radboudumc & National Expert and Training Centre for Breast Cancer Screening,
The EU strategy in Horizon2020 to fight poverty related diseases
Meeting on EDCTP2 French Ministry of Education, Science and Innovation, Paris 30 June 2017 The EU strategy in Horizon2020 to fight poverty related diseases Line Matthiessen Acting Director Health Directorate
The HIV Prevention England programme: what s next? Cary James May 2016
The HIV Prevention England programme: what s next? Cary James May 2016 Summary Programme objectives Campaign evolution Sector development Structure and governance Support for HIV prevention system Communication
EU funding of animal health research
EU funding of animal health research Jean-Charles CAVITTE Research Policy Officer Research and Innovation Unit European Commission DG Agriculture and Rural Development The presentation shall neither be
15050/15 JS/pm 1 DGB 3B
Council of the European Union Brussels, 7 December 2015 (OR. en) 15050/15 SAN 427 OUTCOME OF PROCEEDINGS From: General Secretariat of the Council On: 7 December 2015 To: Delegations No. prev. doc.: 14391/1/15
The new PH landscape Opportunities for collaboration
The new PH landscape Opportunities for collaboration Dr Ann Hoskins Director Children, Young People & Families Health and Wellbeing Content Overview of new PH system PHE function and structure Challenges
DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION
DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people
Exemplary Project. O.P.E.C.E. - LUXEMBOURG April 2018
Exemplary Project O.P.E.C.E. - LUXEMBOURG April 2018 This document was prepared as part of the EU-funded project: ESIF Support in the area of health: building knowledge and capacities for monitoring and
Table Of Content. Page 1/8
Table Of Content 22nd Conference: Changing perceptions, practice and policy... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04-00 - Programme and book of abstracts (EN)...
European actions in the field of transplantation & blood transfusion
European actions in the field of transplantation & blood transfusion Andrzej Rys Director Directorate Health Systems and Products Madrid, 27 June 2013 1 Blood Tissues and cells Organs 2 Blood transfusion
CHARTING THE COURSE FOR CANADA S NATIONAL DEMENTIA STRATEGY PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE
CHARTING THE COURSE FOR CANADA S NATIONAL DEMENTIA STRATEGY PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE AUGUST 4, 2017 Alzheimer Society of Canada 2018 Pre-Budget Submission
The European Asthma Research & Innovation Partnership tackling Europe s high asthma prevalence and death rates
The European Asthma Research & Innovation Partnership tackling Europe s high asthma prevalence and death rates Drug Delivery to the Lungs Conference, December 2016 Samantha Walker PhD, Director, Research
The European Brain Council
The European Brain Council Dr C. Ian Ragan, Executive Director Dr Mary G. Baker MBE, Vice President Committee on Industry, Research and Energy Public Hearing on Mental Health Research: Scientific Progress
First European Parliament Conference on Complementary and Alternative Medicine, CAM.
First European Parliament Conference on Complementary and Alternative Medicine, CAM. The first ever conference at the European institutions on Complementary and Alternative Medicine, CAM, took place on
Making dementia a European priority
Making dementia a European priority Glasgow 1 June 2015 Jean Georges, Executive Director Alzheimer Europe 36 associations in 31 countries 2 Paris Declaration Adopted by Annual General Meeting in Paris
ROLE SPECIFICATION FOR MACMILLAN GPs
ROLE SPECIFICATION FOR MACMILLAN GPs November 2010 History of Macmillan GPs Macmillan Cancer Support has funded GP positions from the early 1990 s, following the success of our investment in supporting
Draft of the Rome Declaration on Nutrition
Draft of the Rome Declaration on Nutrition 1. We, Ministers and Plenipotentiaries of the Members of the World Health Organization and the Food and Agriculture Organization of the United Nations, assembled
Submission to Standing Committee on Health. With no leadership, Canada s diabetes crisis will continue to get worse
Submission to Standing Committee on Health With no leadership, Canada s diabetes crisis will continue to get worse Diabetes Canada May 23, 2018 Overview Diabetes Canada is very proud to represent the estimated
Non communicable diseases
Non communicable diseases Information Day, Brussels 8 July 2016 K. Berkouk, PhD Deputy Head of Unit, Non-Communicable Diseases and the challenge of Healthy Ageing, European Commission NCD A Global challenge
Priority Medicines for Europe and the World: Setting a public health based medicines development agenda
Priority Medicines for Europe and the World: Setting a public health based medicines development agenda Warren Kaplan, Veronika Wirtz (BU School of Public Health) Aukje Mantel, Pieter Stolk (UU) Béatrice
Worcestershire's Autism Strategy
Worcestershire Health and Well-being Board Worcestershire's Autism Strategy 2014-17 Fulfilling and Rewarding Lives for adults with autism spectrum conditions Find out more online: www.worcestershire.gov.uk/healthandwellbeingboard
THE VALUE OF TREATMENT FOR BRAIN DISORDERS A NEW VISION IN PROGRESS...
V T THE VALUE OF TREATMENT FOR BRAIN DISORDERS A NEW VISION IN PROGRESS... BRIEF DESCRIPTION The European Brain Council (EBC) is carrying out a new research project for 2015-2017 on The value of treatment
NORDIC CONFERENCE ON RARE DISEASES
www.eurordis.org NORDIC CONFERENCE ON RARE DISEASES 31 May 2012, Reykjavik, Iceland www.eurordis.org RARE DISEASES IN EUROPE Terkel ANDERSEN President of EURORDIS European Organisation for Rare Diseases
Table Of Content. Page 1/8
Table Of Content First European Day of the Brain. Ageing, Stroke and Alzheimer s Disease-finding innovative solutions.... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D01-01
COU CIL OF THE EUROPEA U IO. Brussels, 27 July /09 ADD 2 SA 202 SOC 459 RECH 237 COVER OTE
COU CIL OF THE EUROPEA U IO Brussels, 27 July 2009 12392/09 ADD 2 COVER OTE from: SA 202 SOC 459 RECH 237 Secretary-General of the European Commission, signed by Mr Jordi AYET PUIGARNAU, Director date
ARE Position Paper: Women and Sustainable Energy
ARE Position Paper: Women and Sustainable Energy The Alliance for Rural Electrification (ARE) supports the initiative planned by the European Commission (EC) to empower women in the sustainable energy
Maltese Presidency of the Council of the European Union. Ministry for Health
Maltese Presidency of the Council of the European Union Ministry for Health The Trio programme Guided by the strategic agenda of the European Council adopted in June 2014 One of the common priority areas
The EU rare diseases policy framework: the context for ERNs
The EU rare diseases policy framework: the context for ERNs Jaroslaw Waligora DG Health and Food Safety, European Commission Unit C.1, Programme Management and Diseases Report from an expert group of the
Healthy Lives & Healthy Food
Healthy Lives & Healthy Food Sasha Hugentobler Health NCP Euresearch Head Office health@euresearch.ch Gerhard Gass Bio NCP Euresearch Head Office Gerhard.gass@euresearch.ch Healthy Lives & Healthy Food
Foreword. Our shared principles
Our Digital Future Foreword The way we manage our lives is changing. 86% of households now have internet access, 82% of people go online every day and 72% of adults use a smartphone 1. It is now time to
FP7 PEOPLE PROGRAMME. MARIE CURIE Host - Driven ACTIONS Calls 2012
FP7 PEOPLE PROGRAMME MARIE CURIE Host - Driven ACTIONS Calls 2012 Laura APOSTOL Research Executive Agency (REA) Unit P4, Marie Curie Host-Driven Actions 1 MC Actions FP7 overview (2007-2013) FP7 breakdown
Action Plan on HIV/AIDS in the EU and neighbouring countries:
Action Plan on HIV/AIDS in the EU and neighbouring countries: 2014-2016 Matthias Schuppe Policy Officer Health Threats Unit DG Health and Consumers European Commission Outline o EU policy framework on
Symposium Gendered Innovations. March 28, Simone Buitendijk
Symposium Gendered Innovations March 28, 2014 Simone Buitendijk Today we are discussing gendered innovations, a very important new development in science and research with particular importance to the
Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.
Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on the Budget Hearing on: 2:00 p.m. 210 Cannon House Office Building National Association of Chain
R&D Status in Romania
R&D Status in Romania Romania Economy is the second largest country in the Central and Eastern Europe (after Poland); it has a population of 22 million people; it benefits from a strategic geographic position;
E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES. RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY
E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY E-RARE THE ERA-NET FOR RESEARCH PROGRAMMES ON RARE DISEASES MAJOR FACTS ABOUT E-RARE ERA-NET
From IMI to IMI2. Hugh Laverty Senior Scientific Project Manager
From IMI to IMI2 Hugh Laverty Senior Scientific Project Manager FitForHealth June 2014 Innovative Medicines Initiative: Joining forces in the healthcare sector The biggest public/private partnership in
An Active Inclusive Capital. A Strategic Plan of Action for Disability in London
An Active Inclusive Capital A Strategic Plan of Action for Disability in London Angus Robertson Director of Operations, London Sport In 2015, London s Blueprint for a Physically Active City was launched,
Multi-sectoral aspects of pandemic preparedness and response
Multi-sectoral aspects of pandemic preparedness and response Best practices, challenges and lessons learned in the EU International Ministerial Conference on Avian & Pandemic Influenza Sharm el Sheikh,
ADVANTAGE JA Joint Action on Prevention and Management of frailty Prof. Leocadio Rodríguez Mañas Coordinator ADVANTAGE
ADVANTAGE JA Joint Action on Prevention and Management of frailty 2017-2019 Prof. Leocadio Rodríguez Mañas Coordinator ADVANTAGE A Joint Action with 22 Member States and 43 organizations involved. A comprehensive
EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)
EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUROPEAN REFERENCE NETWORKS FOR RARE DISEASES IN EUROPE: THE CONTEXT The need for European Reference Networks (ERNs) for rare
PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH
PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH Vaccines Europe calls for EU leadership to develop a comprehensive EU vaccination strategy aimed to support Member States in implementing effective
Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK
Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK 1. Introduction 1.1. Alzheimer s Research UK is the UK s leading dementia research charity. As research experts,
Retina International General Assembly Auckland, New Zealand
Retina International General Assembly 2018 - Auckland, New Zealand Thursday, February 8th, 2018 Location: University of Auckland Business School Owen G Glenn Building, 12 Grafton Road, Auckland, 1010 Room:
14 December :00 CET
Webinar IMI2 Call 13 Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches 14 December 2017 15:00 CET Agenda How to use
On the occasion of World Digestive Health Day 2013: The importance of research into liver cancer and alcohol as a risk factor
On the occasion of World Digestive Health Day 2013: The importance of research into liver cancer and alcohol as a risk factor Introduction On May 29 2013 EASL and UEG organised the event The importance
Moorfields Eye Charity Strategy People's sight matters
Moorfields Eye Charity Strategy 2018-2024 People's sight matters Welcome to the strategy for Moorfields Eye Charity 2018-2024 Our strategy builds on the Vision of Excellence strategy from Moorfields Eye
INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA
Photo by Dominic Chavez INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA Private Sector Engagement in the Global Financing Facility in Support of Every Woman Every Child 1 www.globalfinancingfacility.org
Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016
Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Please note that all information in this document is also disclosed in the overall report on Pfizer
Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs
Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs Overview and summary of feedback 18-19 February 2015 Summary (from policy
Dementia in England. Dr Charles Alessi Senior Advisor on Dementia, Public Health England
Dementia in England Dr Charles Alessi Senior Advisor on Dementia, Public Health England The health and care system in England National Health Service (NHS) World s largest publicly funded health service
SUPPORTING COMPANIES GO INTERNATIONAL FOR RESEARCH AND INNOVATION
SUPPORTING COMPANIES GO INTERNATIONAL FOR RESEARCH AND INNOVATION COLLABORATION Insert a picture NEEDS AND GOOD PRACTICES TABLE OF CONTENTS Table of contents... 2 Executive Summary... 3 1. Introduction...
Spreading Excellence and Widening Participation
Spreading Excellence and Widening Participation Dr G Ambroziewicz Ankara, 27/02/2017 Research and Background Disparities in research and innovation performance: barrier to competitiveness, growth and jobs
Towards tailored and targeted asthma self-management using mobile technologies
Towards tailored and targeted asthma self-management using mobile technologies Funded by the European Union Asthma: the problem Asthma is a lifelong chronic disease caused by inflammation of the airways,
ESRC-NIHR dementia research initiative 2018 outline call Call specification
ESRC-NIHR dementia research initiative 2018 outline call Call specification Summary This initiative will fund large grants which will be national or international focal points for social science research
HORIZON The European Union s support for cancer research: towards personalised medicine. The EU Framework Programme for Research and Innovation
The EU Framework Programme for Research and Innovation HORIZON 2020 The European Union s support for cancer research: towards personalised medicine Dominika TRZASKA, PhD Scientific and Policy Officer in
Supplementary Table 1 - Grand priority candidates: Ranking based on percentage of votes received from GP-TCM members and external participants
Supplementary Table 1 - Grand priority candidates: based on percentage of votes received from members and external participants Grand Priorities 1 72.4 7-8 48.6 High-quality research to evaluate the quality
Monitoring of the achievement of the health-related Millennium Development Goals
SIXTY-THIRD WORLD HEALTH ASSEMBLY WHA63.15 Agenda item 11.4 21 May 2010 Monitoring of the achievement of the health-related Millennium Development Goals The Sixty-third World Health Assembly, Having considered
National Dementia Vision for Wales Dementia Supportive Communities
National Dementia Vision for Wales Dementia Supportive Communities Crown Copyright 2011 WAG11-11223 F641 Introduction In Wales, we are justifiably proud of the communities we have built, just as we are
Improving Healthcare Together
Improving Healthcare Together Shared Challenges, Smart Solutions Incoming Visit fom São Paulo, Brazil 14 June 2016, The Hague Dutch Life Sciences & Health Sector 1 of the 9 Topsector in the Netherlands
PUBLIC POLICIES AND ALZHEIMER RESEARCH
PUBLIC POLICIES AND ALZHEIMER RESEARCH 25TH ALHEIMER EUROPE CONFERENCE SEPTEMBER 2015 INTRODUCTION France Alzheimer and related diseases has, since its creation, put research at the center of its priorities
NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016
NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016 NIH s FY 2017 Budget Request Year FY 2015 FY 2016 FY 2017 Request Program Level ($B)
A pan European Dementia Strategy
A pan European Dementia Strategy Luxembourg 13 June 2017 Vanessa Challinor, Policy Officer @vanessachall Agenda Alzheimer Europe Campaign to recognise dementia as policy and research priority National
Open Access to publications and research data in Horizon 2020
Open Access to publications and research data in Horizon 2020 José Cotta Head of Unit - C3.Digital Science DG CONNECT 18/12/13 - ELIXIR Founding Ceremony and Launch Event What do we understand by open
Annual General Meeting
NHS Harrogate and Rural District CCG Annual General Meeting. 2 August 2018 1 Welcome and introductions Dr Alistair Ingram Clinical Chair NHS Harrogate and Rural District Clinical Commissioning Group 2
Australasian Sleep Association
Australasian Sleep Association Submission to The Government s Review Panel Mr Simon McKeon, Prof. Henry Brodaty AO, Prof. Ian Frazer, Prof. Melissa Little, Ms Elizabeth Alexander AM and Mr Bill Ferris
European Innovation Partnership on Active and Healthy Ageing
European Innovation Partnership on Active and Healthy Ageing Jorge PINTO ANTUNES Deputy Head of Unit Innovation for Health DG SANCO, European Commission The challenge of an ageing global population the
OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health
OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents Health Every Woman Every Child 2016 OPERATIONAL FRAMEWORK for the Global Strategy for Women s, Children s and Adolescents
Project Manager Mental Health Job Description and Application Pack
Project Manager Mental Health Job Description and Application Pack Groundswell is seeking an experienced professional for the new role of Project Manager Mental Health. This is an opportunity to develop